KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Aurora Cannabis (ACB) Invested Capital (2018 - 2025)

Aurora Cannabis has reported Invested Capital over the past 8 years, most recently at $479.6 million for Q4 2025.

  • Quarterly Invested Capital fell 32.77% to $479.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $479.6 million through Dec 2025, down 32.77% year-over-year, with the annual reading at $497.0 million for FY2025, 29.67% down from the prior year.
  • Invested Capital was $479.6 million for Q4 2025 at Aurora Cannabis, down from $485.0 million in the prior quarter.
  • Over five years, Invested Capital peaked at $2.1 billion in Q1 2021 and troughed at $177632.0 in Q1 2022.
  • The 5-year median for Invested Capital is $461.7 million (2024), against an average of $460.1 million.
  • Year-over-year, Invested Capital crashed 99.99% in 2022 and then skyrocketed 220131.61% in 2023.
  • A 5-year view of Invested Capital shows it stood at $180087.3 in 2021, then skyrocketed by 7666.4% to $14.0 million in 2022, then surged by 4629.84% to $661.5 million in 2023, then rose by 7.84% to $713.4 million in 2024, then tumbled by 32.77% to $479.6 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Invested Capital are $479.6 million (Q4 2025), $485.0 million (Q3 2025), and $498.2 million (Q2 2025).